Clincosm LogoSign in Get a demo

inflammatory breast cancer

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)

Not yet recruiting
  • Inflammatory Breast Cancer
  • Breast conserving surgery
  • Radical modified mastectomy
  • (no location specified)
Nov 14, 2023

Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer Trial in Canada, Mexico, Spain (drug, procedure,

Recruiting
  • Early Breast Cancer
  • +2 more
  • Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)
  • +6 more
  • Buenos Aires, Argentina
  • +29 more
Jan 31, 2023

Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Boston (Eribulin, Adriamycin,

Active, not recruiting
Has Results
  • Inflammatory Breast Cancer
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Boston, Massachusetts
  • +1 more
Nov 28, 2022

Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)

Recruiting
  • Breast Cancer
  • +5 more
  • MRI
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 9, 2022

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • External beam radiation therapy
  • New Brunswick, New Jersey
  • +1 more
Jan 30, 2022

Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • Duarte, California
  • +1 more
Jul 9, 2021

Inflammatory Breast Cancer Trial (Docetaxel, Cyclophosphamide, Epirubicin)

Completed
  • Inflammatory Breast Cancer
  • (no location specified)
Feb 17, 2021

Breast Cancer Female NOS, Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II Trial in Berlin (Denosumab,

Completed
  • Breast Cancer Female NOS
  • +6 more
  • Berlin, Germany
    Charité Campus Mitte
Feb 1, 2021

Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II, Breast Cancer Female NOS Trial in Berlin (nab-Paclitaxel,

Completed
  • Tubular Breast Cancer Stage II
  • +7 more
  • Berlin, Germany
    Helios-Klinikum Berlin-Buch
Aug 4, 2020

Inflammatory Breast Cancer Trial in Belgium, France (Pembrolizumab Injection, neoadjuvant EC-paclitaxel chemo)

Recruiting
  • Inflammatory Breast Cancer
  • Pembrolizumab Injection
  • neoadjuvant EC-paclitaxel chemotherapy
  • Antwerp, Belgium
  • +17 more
Jun 30, 2020

Invasive Ductal Breast Cancer, Tubular Breast Cancer, Mucinous Breast Cancer Trial in Shanghai (Paclitaxel, Cisplatin,

Recruiting
  • Invasive Ductal Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine, Renji Hospital
Mar 19, 2020

Inflammatory Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in United States (drug, biological, procedure,

Completed
Has Results
  • Inflammatory Breast Cancer
  • +5 more
  • sunitinib malate
  • +7 more
  • Anchorage, Alaska
  • +6 more
Jul 23, 2019

Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer Trial in China (Paclitaxel, Cisplatin,

Active, not recruiting
  • Tubular Breast Cancer
  • +3 more
  • Handan, Hebei, China
  • +7 more
Mar 13, 2019

Breast Cancer, Inflammatory Breast Cancer, Stage I Breast Cancer Trial in Cleveland (MUC-1 peptide vaccine, poly ICLC, MUC1

Completed
  • Breast Cancer
  • +7 more
  • MUC-1 peptide vaccine
  • +5 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 19, 2018

HER2-negative Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer Trial in Philadelphia (Romidepsin, Abraxane)

Terminated
Has Results
  • HER2-negative Breast Cancer
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 4, 2017

Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III, Mucinous Breast Cancer Stage II Trial in Heidelberg

Completed
  • Tubular Breast Cancer Stage II
  • +6 more
  • non-pegylated liposomal doxorubicin
  • +7 more
  • Heidelberg, Baden-Württemberg, Germany
    NTC
Jul 10, 2017

Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Inflammatory Breast Cancer Trial in Seattle

Completed
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +7 more
  • tamoxifen citrate
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/Puget Sound Oncology Cons
Jun 16, 2017

Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia

Completed
  • Inflammatory Breast Cancer
    • Cairo, Egypt
    • +3 more
    Jun 30, 2017

    Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer Trial in Shanghai (Paclitaxel, Cisplatin)

    Completed
    • Tubular Breast Cancer
    • +3 more
    • Shanghai, Shanghai, China
    • +1 more
    Jan 23, 2017

    Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II, Breast Cancer Female NOS Trial in Fürstenwalde, Düsseldorf,

    Completed
    • Tubular Breast Cancer Stage II
    • +7 more
    • Fürstenwalde, Brandenburg, Germany
    • +2 more
    Feb 12, 2016

    Inflammatory Breast Cancer Trial in Bab Saadoun (Bevacizumab, Cyclophosphamide, epirubicin HCl)

    Unknown status
    • Inflammatory Breast Cancer
    • Bevacizumab
    • +5 more
    • Bab Saadoun, Tunis, Tunisia
      Institut Salah Azaiz
    Jun 14, 2013

    Inflammatory Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Bronx (drug, biological, procedure, other)

    Completed
    • Inflammatory Breast Cancer
    • +4 more
    • doxorubicin hydrochloride
    • +5 more
    • Bronx, New York
      Albert Einstein College of Medicine
    Jun 5, 2013

    Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

    Completed
    • Advanced Adult Primary Liver Cancer
    • +126 more
    • recombinant interleukin-12
    • ABI-007/carboplatin/trastuzumab
    • Columbus, Ohio
      Ohio State University Medical Center
    Feb 27, 2013